☆ 4.5 Article

Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid

INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)

Get Full Text
Add to Collection

Journal

INTERNATIONAL JOURNAL OF DERMATOLOGY
Volume 57, Issue 11, Pages 1372-1374

Publisher

WILEY
DOI: 10.1111/ijd.13970

Keywords

-

Categories

Dermatology

Funding

  1. Bristol-Myers Squibb
  2. Prometheus
  3. Regeneron
  4. Tracon
  5. Biogene
  6. Celgene
  7. Eli Lilly Company
  8. XBiotech

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.